Active Ingredient: MIDAZOLAM
Proprietary Name: MIDAZOLAM IN 0.9% SODIUM CHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 100MG/100ML (1MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A216159
Product Number: 002
Approval Date: Apr 17, 2023
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
